139 related articles for article (PubMed ID: 12737328)
1. Osteoclast formation from circulating precursors in osteoporosis.
Jevon M; Hirayama T; Brown MA; Wass JA; Sabokbar A; Ostelere S; Athenasou NA
Scand J Rheumatol; 2003; 32(2):95-100. PubMed ID: 12737328
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
Hirayama T; Danks L; Sabokbar A; Athanasou NA
Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
4. Gender- and age-related differences in osteoclast formation from circulating precursors.
Jevon M; Sabokbar A; Fujikawa Y; Hirayama T; Neale SD; Wass J; Athanasou NA
J Endocrinol; 2002 Mar; 172(3):673-81. PubMed ID: 11874715
[TBL] [Abstract][Full Text] [Related]
5. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis.
D'Amelio P; Grimaldi A; Pescarmona GP; Tamone C; Roato I; Isaia G
FASEB J; 2005 Mar; 19(3):410-2. PubMed ID: 15611151
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
[TBL] [Abstract][Full Text] [Related]
9. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
10. Influence of glucocorticoids on human osteoclast generation and activity.
Sivagurunathan S; Muir MM; Brennan TC; Seale JP; Mason RS
J Bone Miner Res; 2005 Mar; 20(3):390-8. PubMed ID: 15746983
[TBL] [Abstract][Full Text] [Related]
11. The generation of highly enriched osteoclast-lineage cell populations.
Quinn JM; Whitty GA; Byrne RJ; Gillespie MT; Hamilton JA
Bone; 2002 Jan; 30(1):164-70. PubMed ID: 11792580
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease.
Hirayama T; Sabokbar A; Itonaga I; Watt-Smith S; Athanasou NA
J Pathol; 2001 Dec; 195(5):624-30. PubMed ID: 11745700
[TBL] [Abstract][Full Text] [Related]
13. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
14. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
15. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of bone resorption in breast carcinoma.
Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA
Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.
Matsuzaki K; Udagawa N; Takahashi N; Yamaguchi K; Yasuda H; Shima N; Morinaga T; Toyama Y; Yabe Y; Higashio K; Suda T
Biochem Biophys Res Commun; 1998 May; 246(1):199-204. PubMed ID: 9600092
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
20. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
Flanagan AM; Massey HM; Wilson C; Vellodi A; Horton MA; Steward CG
Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
